GSK1292263

Overview

GSK-1292263 is an orally available GPR119 agonist with pEC 50 s of 6.9 and 6.7 for human and rat GPR119 , respectively. GSK-1292263 can be used for the research of type 2 diabetes mellitus (T2DM).

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > GPR119

Product Information

• Catalog No.: HY-12066
• CAS No.: 1032823-75-8
• Molecular Formula: C23H28N4O4S
• Molecular Weight: 456.56
• Purity: 98.68%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2 mg/mL (4.38 mM); Clear solution
• Availability: In-stock

Source

Original product source